A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Inclusion Criteria:
Exclusion Criteria:
Charlotte, North Carolina 28277, United States
CABA, C1414AIF, Argentina
Capitalfederal, C1425BEN, Argentina
San Juan Bautista, 01888, Argentina
Frankfurt am Main, 60596, Germany
Kitakyushu-shi, 802-0052, Japan
Mizunami-shi, 509-6134, Japan
Sakaide-shi, 762-8550, Japan
Shinagawa-ku, 140-8522, Japan
Toshima-ku, 170-0003, Japan
Yokkaichi-shi, 510-8561, Japan
Ostrowiec Świętokrzyski, 27-400, Poland